Development Of Support Devices Research Articles

On the viability of electrochemical carbon dioxide in-situ resource utilization to produce chemical feedstocks on Mars

The long-term, crewed exploration of Mars is a priority for both national and private space entities. Given economical constraints on the mass sent off-world from Earth, in situ resource utilization (ISRU) through ultra-low temperature CO2-H2O electrolyzer technology that is fed using the Martian atmosphere’s CO2 (∼95 %) and the subsurface Martian water cycle (enabled by perchlorate salts that depress the Martian brine’s freezing point to < 213 K) has been proposed as a pathway towards fuel and chemical feedstock. Herein we applied a validated, computationally frugal electrolyzer model to a Martian CO2-H2O electrolyzer and examined its viability. Through a judicious combination of catalysts, such electrolyzers could produce O2, CO, HCHO, CH3OH, CH4, C2H4, and C2H5OH even at ambient Martian temperatures (∼237 K). Our modeling herein shows the theoretical production of these key resources in acidic electrolyzers to be at a scalable rate of 0.052 – 1.13 g per cm2 per day of CO, 0.0004 – 0.086 g per cm2 per day of CH3OH, 0.001–0.048 g per cm2 per day of CH4, 0.0164 – 0.171 g per cm2 per day of C2H4, 0.008 – 0.0125 g per cm2 per day of C2H5OH. A range of catalyst candidates were examined for product selectivity, energy efficiency and throughput. Ambient temperature CO2-H2O electrolysis is shown to be an energy efficient approach to chemical feedstocks needed for the sustained exploration of Mars and beyond. This model can inform future astronaut life support device development for NASA and other space faring entities.

Reconsidering Ventriculoperitoneal Shunt Surgery and Postoperative Shunt Valve Pressure Adjustment: Our Approaches Learned From Past Challenges and Failures.

Treatment for idiopathic normal pressure hydrocephalus (iNPH) continues to develop. Although ventriculoperitoneal shunt surgery has a long history and is one of the most established neurosurgeries, in the 1970s, the improvement rate of iNPH triad symptoms was poor and the risks related to shunt implantation were high. This led experts to question the surgical indication for iNPH and, over the next 20 years, cerebrospinal fluid (CSF) shunt surgery for iNPH fell out of favor and was rarely performed. However, the development of programmable-pressure shunt valve devices has reduced the major complications associated with the CSF drainage volume and appears to have increased shunt effectiveness. In addition, the development of support devices for the placement of ventricular catheters including preoperative virtual simulation and navigation systems has increased the certainty of ventriculoperitoneal shunt surgery. Secure shunt implantation is the most important prognostic indicator, but ensuring optimal initial valve pressure is also important. Since over-drainage is most likely to occur in the month after shunting, it is generally believed that a high initial setting of shunt valve pressure is the safest option. However, this does not always result in sufficient improvement of the symptoms in the early period after shunting. In fact, evidence suggests that setting the optimal valve pressure early after shunting may cause symptoms to improve earlier. This leads to improved quality of life and better long-term independent living expectations. However, in iNPH patients, the remaining symptoms may worsen again after several years, even when there is initial improvement due to setting the optimal valve pressure early after shunting. Because of the possibility of insufficient CSF drainage, the valve pressure should be reduced by one step (2–4 cmH2O) after 6 months to a year after shunting to maximize symptom improvement. After the valve pressure is reduced, a head CT scan is advised a month later.

Polyacrylamide hydrogel phantoms for performance evaluation of multispectral photoacoustic imaging systems

As photoacoustic imaging (PAI) begins to mature and undergo clinical translation, there is a need for well-validated, standardized performance test methods to support device development, quality control, and regulatory evaluation. Despite recent progress, current PAI phantoms may not adequately replicate tissue light and sound transport over the full range of optical wavelengths and acoustic frequencies employed by reported PAI devices. Here we introduce polyacrylamide (PAA) hydrogel as a candidate material for fabricating stable phantoms with well-characterized optical and acoustic properties that are biologically relevant over a broad range of system design parameters. We evaluated suitability of PAA phantoms for conducting image quality assessment of three PAI systems with substantially different operating parameters including two commercial systems and a custom system. Imaging results indicated that appropriately tuned PAA phantoms are useful tools for assessing and comparing PAI system image quality. These phantoms may also facilitate future standardization of performance test methodology.

Population-specific material properties of the implantation site for transcatheter aortic valve replacement finite element simulations

Patient-specific computational models are an established tool to support device development and test under clinically relevant boundary conditions. Potentially, such models could be used to aid the clinical decision-making process for percutaneous valve selection; however, their adoption in clinical practice is still limited to individual cases. To be fully informative, they should include patient-specific data on both anatomy and mechanics of the implantation site. In this work, fourteen patient-specific computational models for transcatheter aortic valve replacement (TAVR) with balloon-expandable Sapien XT devices were retrospectively developed to tune the material parameters of the implantation site mechanical model for the average TAVR population.Pre-procedural computed tomography (CT) images were post-processed to create the 3D patient-specific anatomy of the implantation site. Balloon valvuloplasty and device deployment were simulated with finite element (FE) analysis. Valve leaflets and aortic root were modelled as linear elastic materials, while calcification as elastoplastic. Material properties were initially selected from literature; then, a statistical analysis was designed to investigate the effect of each implantation site material parameter on the implanted stent diameter and thus identify the combination of material parameters for TAVR patients.These numerical models were validated against clinical data. The comparison between stent diameters measured from post-procedural fluoroscopy images and final computational results showed a mean difference of 2.5 ± 3.9%. Moreover, the numerical model detected the presence of paravalvular leakage (PVL) in 79% of cases, as assessed by post-TAVR echocardiographic examination.The final aim was to increase accuracy and reliability of such computational tools for prospective clinical applications.

The Development of Supporting Device for Direct Moxibustion

The Development of Supporting Device for Direct Moxibustion

Development of Supporting Device to Sitting Up Motion for Parkinson's Disease Patients

Development of Supporting Device to Sitting Up Motion for Parkinson's Disease Patients

Verification and Validation of an Open Source–Based Morphology Analysis Platform to Support Implant Design

Availability of medical image data and ongoing advancement of image-processing and mathematical-modeling techniques are increasingly enabling device manufacturers to conduct clinically relevant morphological and mechanical analyses across populations to support device development. Gaps in the ability of contemporary commercial codes to fully realize these analytical goals frequently requires some amount of in-house code development and deployment. Verification and validation (V&amp;V) of these custom modules or platforms is an essential requirement for deployment of the software within a medical device design controls system. One such software platform to support orthopedic morphological analysis, zibra, has been successfully developed through a collaborative relationship between Zimmer, Inc. and Kitware, Inc. The development process involved configuration of commercial code, open-source toolkits, and custom code. Here, the V&amp;V strategy to support deployment of zibra is described.